Aillis
About:
Aillis is an AI-powered medical device for early and accurate influenza detection in the development of innovative medical devices.
Website: https://aillis.jp/
Top Investors: Shionogi, Nissay Capital, MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC), Beyond Next Ventures, Cyberdyne
Description:
Aillis specializes in the development of testing methods for Influenza using artificial intelligence technology. The company mainly focuses on new methods of diagnosing influenza. The company was founded in 2017.
Total Funding Amount:
1.25B JPY
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Tokyo, Tokyo, Japan
Founded Date:
2017-11-01
Contact Email:
sho.okiyama(AT)aillis.jp
Founders:
Sho Okiyama
Number of Employees:
51-100
Last Funding Date:
2022-01-01
IPO Status:
Private
© 2024 MyAiNote.com